Follow-up of patients with advanced NSCLC following 1st line chemotherapy. A British Thoracic Oncology Group national survey by Darlison, L, Beckett, P, Calman, L, Mulatero, C, O'Byrne, K, Peake, M, Talbot, D

BTS guideline for the investigation and management of malignant pleural mesothelioma by Woolhouse, I, Bishop, L, Darlison, L, de Fonseka, D, Edey, A, Edwards, J, Faivre-Finn, C, Fennell, D, Holmes, S, Kerr, K, Nakas, A, Peel, T, Rahman, N, Slade, M, Steele, J, Tsim, S, Maskell, N

British Thoracic Society Guideline for the investigation and management of malignant pleural mesothelioma by Woolhouse, I, Bishop, L, Darlison, L, De Fonseka, D, Edey, A, Edwards, J, Faivre-Finn, C, Fennell, D, Holmes, S, Kerr, K, Nakas, A, Peel, T, Rahman, N, Slade, M, Steele, J, Tsim, S, Maskell, N

Mesothelioma and Radical Surgery 2 (MARS 2): protocol for a multicentre randomised trial comparing (extended) pleurectomy decortication versus no (extended) pleurectomy decorticati... by Lim, E, Darlison, L, Edwards, J, Elliott, D, Fennell, DA, Popat, S, Rintoul, RC, Waller, D, Ali, C, Bille, A, Fuller, L, Ionescu, A, Keni, M, Kirk, A, Koh, P, Lau, K, Mansy, T, Maskell, NA, Milton, R, Muthukumar, D, Pope, T, Roy, A, Shah, R, Shamash, J, Tasigiannopoulos, Z, Taylor, P, Treece, S, Ashton, K, Harris, R, Joyce, K, Warnes, B, Mills, N, Stokes, EA, Rogers, C, MARS 2 Trialists